These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28634055)
1. An insight on the association of glycation with hepatocellular carcinoma. Jabir NR; Ahmad S; Tabrez S Semin Cancer Biol; 2018 Apr; 49():56-63. PubMed ID: 28634055 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease. Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680 [TBL] [Abstract][Full Text] [Related]
3. AGEs, RAGEs and s-RAGE; friend or foe for cancer. Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719 [TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions. Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227 [TBL] [Abstract][Full Text] [Related]
5. Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. Ahmad S; Khan MY; Rafi Z; Khan H; Siddiqui Z; Rehman S; Shahab U; Khan MS; Saeed M; Alouffi S; Khan MS Semin Cancer Biol; 2018 Apr; 49():29-36. PubMed ID: 29055529 [TBL] [Abstract][Full Text] [Related]
6. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation. Yamagishi SI; Sotokawauchi A; Matsui T Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960 [TBL] [Abstract][Full Text] [Related]
7. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Neviere R; Yu Y; Wang L; Tessier F; Boulanger E Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623 [TBL] [Abstract][Full Text] [Related]
8. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma. Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691 [TBL] [Abstract][Full Text] [Related]
9. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor. Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591 [TBL] [Abstract][Full Text] [Related]
10. The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). Hollenbach M Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156655 [TBL] [Abstract][Full Text] [Related]
11. Do all roads lead to the Rome? The glycation perspective! Ahmad S; Akhter F; Shahab U; Rafi Z; Khan MS; Nabi R; Khan MS; Ahmad K; Ashraf JM; Moinuddin Semin Cancer Biol; 2018 Apr; 49():9-19. PubMed ID: 29113952 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Rojas A; Añazco C; González I; Araya P Carcinogenesis; 2018 Apr; 39(4):515-521. PubMed ID: 29373651 [TBL] [Abstract][Full Text] [Related]
13. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. Petriv N; Neubert L; Vatashchuk M; Timrott K; Suo H; Hochnadel I; Huber R; Petzold C; Hrushchenko A; Yatsenko AS; Shcherbata HR; Wedemeyer H; Lichtinghagen R; Falfushynska H; Lushchak V; Manns MP; Bantel H; Semchyshyn H; Yevsa T Oncoimmunology; 2021 Feb; 10(1):1874159. PubMed ID: 33628620 [TBL] [Abstract][Full Text] [Related]
15. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Hiwatashi K; Ueno S; Abeyama K; Kubo F; Sakoda M; Maruyama I; Hamanoue M; Natsugoe S; Aikou T Ann Surg Oncol; 2008 Mar; 15(3):923-33. PubMed ID: 18080716 [TBL] [Abstract][Full Text] [Related]
16. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668 [TBL] [Abstract][Full Text] [Related]
17. Activation of the receptor for advanced glycation end products and consequences on health. Wautier MP; Guillausseau PJ; Wautier JL Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394 [TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. Pinto RS; Minanni CA; de Araújo Lira AL; Passarelli M Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269546 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs. Deluyker D; Evens L; Bito V Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551 [TBL] [Abstract][Full Text] [Related]
20. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes. Yang P; Feng J; Peng Q; Liu X; Fan Z Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]